Riskpilot← Back to searchSign inGet full accessSana Pharma Sverige AB
ABActiveOrg 5590625843Hotellplatsen 2 3trWholesale of pharmaceutical and medical goods · NACE 4646Est. 20165 employees
Revenue 2024
SEK 7,7M
+20% vs 2023
EBITDA margin
-17.3%
-843% vs 2023
Equity ratio
6.3%
Financial strength
Net profit 2024
SEK -1,4M
-1033% vs 2023
| Revenue | SEK 7,7M | +20% |
| EBITDA | SEK -1,3M | -843% |
| Net profit | SEK -1,4M | -1033% |
| Total assets | SEK 16,4M | +64% |
| Equity | SEK 1M | +158% |
| Employees | 5 | — |
Legal name
Sana Pharma Sverige AB
Org number
5590625843
Legal form
Aktiebolag
NACE code
4646 · Wholesale of pharmaceutical and medical goods
Founded
13 maj 2016
Share capital
SEK 50 000
Employees
5 (FTE)
VAT registered
Yes
Audit selected
No
Last report
2024-12-31
Financial year
January – December
Signatory rights
Firman tecknas av styrelsen Dessutom har verkställande direktören rätt att teckna firman beträffande löpande förvaltningsåtgärder
Company purpose
Bolaget ska bedriva handel med kosttillskott, växtbaserade läkemedel, medicinsk utrustning och annan relaterad verksamhet, samt vara delaktigt i andra bolag med liknande verksamhet samt därmed förenlig verksamhet.
Address
Hotellplatsen 2 3tr
Email
morten@sanapharma.no
Risika for professionals
Risika provides regulated workflow tools for finance, procurement and compliance teams that need monitoring, alerts and an API.
| Item | 2020 | 2021 | 2022 | 2023 | 2024 |
|---|---|---|---|---|---|
| Revenue | 2 285 | 2 892 | 6 931 | 6 396 | 7 706 |
| Staff expenses | — | — | — | — | — |
| EBITDA | 52 | 161 | 25 | 179 | −1 330 |
| Depreciation & amort. | −10 | −21 | −28 | −21 | −27 |
| EBIT | 42 | 140 | −3 | 158 | −1 357 |
| Net financials | — | — | — | −10 | −14 |
| Profit before tax | 42 | 140 | −3 | 147 | −1 371 |
| Tax | −0 | −0 | −0 | −0 | −0 |
| Net profit | 42 | 140 | −3 | 147 | −1 371 |
| Item | 2020 | 2021 | 2022 | 2023 | 2024 |
|---|---|---|---|---|---|
| Total assets | 618 | 963 | 3 550 | 9 985 | 16 351 |
| Equity | 114 | 254 | 251 | 399 | 1 028 |
| Long-term debt | 0 | 0 | 0 | 0 | 0 |
| Short-term debt | 504 | 709 | 3 299 | 9 586 | 15 323 |
| Total debt | 504 | 709 | 3 299 | 9 586 | 15 323 |
EBITDA margin
-17.3%
This company
15.8%
Market median
-209% vs market
20202024
Equity ratio
6.3%
This company
38.2%
Market median
-84% vs market
20202024
Return on equity
-133.4%
This company
18.4%
Market median
-825% vs market
20202024
Net profit margin
-17.8%
This company
8.1%
Market median
-320% vs market
20202024
Asset turnover
0.47×
This company
1.12×
Market median
-58% vs market
20202024
Debt / equity
14.91×
This company
0.62×
Market median
-2305% vs market
20202024
- Annual report 2024Filed via Bolagsverket / SCB · Period 2024-01-01 – 2024-12-31
- Annual report 2023Filed via Bolagsverket / SCB · Period 2023-01-01 – 2023-12-31
- Annual report 2022Filed via Bolagsverket / SCB · Period 2022-01-01 – 2022-12-31
- Annual report 2021Filed via Bolagsverket / SCB · Period 2021-01-01 – 2021-12-31
- Annual report 2020Filed via Bolagsverket / SCB · Period 2020-01-01 – 2020-12-31
| Name | Role | Member since |
|---|---|---|
| Current (2) | ||
HL Authorized Recipient of Service | Authorized Recipient of Service | 2022 |
ML Chief Auditor | Chief Auditor | 2025 |
| Former (2) | ||
AH Chief Auditor | Chief Auditor | 2021 – 2025 |
JU Authorized Recipient of Service | Authorized Recipient of Service | 2021 – 2022 |
| Name | Role | Member since |
|---|---|---|
| Current (3) | ||
| Chairman | 2022 | |
| Deputy Board Member | 2022 | |
| Board of Directors | 2022 | |
| Former (4) | ||
| Chairman | 2022 – 2023 | |
| Chairman | 2021 – 2022 | |
| Board of Directors | 2021 – 2022 | |
| Deputy Board Member | 2021 – 2022 | |
| Shareholder | Type | Ownership | Votes | Since |
|---|---|---|---|---|
| Company | 100% | 100% | 2025 | |
| Company | 100% | 100% | 0001 |
Beneficial ownership (UBO) data access is restricted in Denmark as of September 2025 per the EU 6th AML Directive. Learn more.
SANA PHARMA MEDICAL AS
Sana Pharma Sverige AB (this company)Board members of Sana Pharma Sverige AB also hold positions in 0 other companies.
| Person | Role here | Other companies |
|---|---|---|
| Helen Linnea Höyland | Authorized Recipient of Service | 0 companies |
| Anna Hélène Maria Westberg | Chief Auditor | 0 companies |
| Jenny Ulrika Sundbom Otterhäll | Authorized Recipient of Service | 0 companies |
| Malin Lanneborn | Chief Auditor | 0 companies |
| Heidi Tveit | Chairman | 0 companies |
| Anna Sylvia Bentinger Elmblad | Deputy Board Member | 0 companies |
| Per Anders Larnholt | Chairman | 0 companies |
| Kenneth Bern | Chairman | 0 companies |
| Morten Brennesvik-Jensen | Board of Directors | 0 companies |
| Andres Flaaten | Board of Directors | 0 companies |
| Beate Flaaten | Deputy Board Member | 0 companies |